Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 2.5T | 2.3T | 2.6T | 2.3T |
Cost of revenue | 1.8T | 1.6T | 2.0T | 1.7T |
Gross profit | 719.3B | 633.2B | 655.1B | 574.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 489.2B | 433.0B | 460.2B | 443.9B |
Other operating expenses | — | — | — | — |
Operating income | 230.1B | 200.2B | 194.9B | 130.5B |
Non operating interest income | ||||
Income | 8.8B | 10.3B | 8.5B | 11.2B |
Expense | 16.0B | 17.3B | 19.9B | 17.6B |
Other income expense | — | — | — | — |
Pretax income | 183.7B | 320.1B | 206.6B | 115.5B |
Tax provision | 33.5B | 75.9B | 55.9B | 33.8B |
Net income | 150.2B | 244.2B | 150.7B | 81.7B |
Basic EPS | — | 254.8 | 149.6 | 74.8 |
Diluted EPS | — | 254.5 | 149.4 | 74.7 |
Basic average shares | — | 926.3M | 929.6M | 936.3M |
Diluted average shares | — | 927.3M | 930.7M | 937.3M |
EBITDA | 300.7B | 440.9B | 352.2B | 254.5B |
Net income from continuing op. | 150.2B | 244.2B | 150.7B | 81.7B |
Minority interests | -5.4B | -8.2B | -11.6B | -11.7B |
Preferred stock dividends | 0 | 0 | 0 | 0 |